shows the results of a diagnostic test presented in a 2x2 table: columns summarise gold standard results and the rows summarise test results. The labels positive and negative refer to the presence or absence, respectively, of the condition of interest. The number of subjects with the condition testing positive and negative are denoted by a and c. The number of subjects without the condition testing positive and negative are denoted by b and d. The total number of study subjects should be a + b + c + d.
The basic measures to quantify the diagnostic accuracy of a test include sensitivity and specificity 1 . The sensitivity of a diagnostic test quantifies its ability to correctly identify subjects with the disease condition. It is the proportion of true positives that are correctly identified by the test, given by: The specificity is the ability of a test to correctly identify subjects without the condition. It is the proportion of true negatives that are correctly identified by the test: As both sensitivity and specificity are proportions, their confidence intervals can be computed using the standard methods for proportions 2 .
The PPV and NPV are the other two basic measures of diagnostic accuracy. They are related to sensitivity and specificity through disease prevalence (∏). The PPV is the probability that the disease is present given a positive test result, and is defined as:
Similarly, the NPV is the probability that the disease is absent given a negative test result, and is defined as:
As both PPV and NPV are related to sensitivity, specificity and ∏ :
(a) PPV is greater when ∏ is high and PPV is always greater than ∏. Hence, when a disease is rare (i.e. ∏ is low), a greater specificity is needed to achieve a higher PPV.
(b) NPV is greater when ∏ is low and NPV is always greater than 1 -∏. Hence, when a disease is common (i.e. ∏ is high), a greater sensitivity is needed to achieve a higher NPV. Figure 1 illustrates the effect of disease prevalence on PPV and NPV when both sensitivity and specificity are fixed at 0.95. The results show that increasing disease prevalence, ∏, will lead to an increasing PPV but a decreasing NPV of a diagnostic test.
To illustrate the above-mentioned calculations for sensitivity, specificity, PPV and NPV, consider an example of a diagnostic mammography study of 6,152 women with signs or symptoms of breast cancer (Table 2 ). This data was retrieved from a one-year study of women from the New Hampshire Mammography Network (NHMN) which was designed to describe key performance measures of screening and diagnostic breast radiography 3 . A positive cancer status was defined as any tissue specimen, including malignant cytologic findings, revealing invasive carcinoma or ductal carcinoma in-situ reported within a year. We have shown mathematically that the prevalence of a condition affects the PPV and NPV of the test; however, it is worthy to note that, prevalence does not affect the sensitivity and specificity of a diagnostic or screening test. This is because sensitivity and specificity are calculated from subgroups of subjects with and without the disease condition, respectively. Given this mathematical property, the implication is that measures of sensitivity and specificity can be computed and compared across study populations with different prevalence rates, although this assumes populations do not differ in important characteristics (e.g. disease severity) that would affect sensitivity and specificity of the diagnostic test.
Although the sensitivity and specificity of diagnostic tests are not affected by the prevalence of the condition, they can be influenced by differences in disease characteristics (such as clinical severity or anatomic extent of a disease) and characteristics of subjects such as age and breast density in the diagnostic mammography study 4 . For example, large, palpable breast cancer tumours or lesions in fatty, less dense breasts of older women are easier to detect with mammography. Hence, mammography has greater sensitivity when it is used in patients with advanced breast cancer or in older women. It is thus critical to evaluate the group of subjects to whom the diagnostic test has been applied when the sensitivity and specificity of two diagnostics tests are compared.
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